Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2
Kei Yoshino, Tetsuya Hosooka, Masakazu Shinohara, Chikako Aoki, Yusei Hosokawa, Makoto Imamori, Wataru Ogawa
Topics & Concepts
CanagliflozinEndocrinologyInternal medicineNonalcoholic fatty liver diseaseProstaglandin E2MedicineChemistryDiabetes mellitusFatty liverType 2 diabetesDiseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseasePancreatic function and diabetes